Lv5
1120 积分 2021-09-09 加入
Early Detection of Molecular Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA
2个月前
已完结
Complexities of Measurable Residual Disease Assays in Acute Lymphoblastic Leukemia: A Guide for the Practicing Clinician
4个月前
已关闭
How I treat chronic myeloid leukemia in children and adolescents
5个月前
已完结
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia
5个月前
已完结
儿童白血病微小残留病监测与临床应用指南（2026）
6个月前
已完结
Functional precision cancer medicine—moving beyond pure genomics
7个月前
已完结
Circulating tumor DNA (ctDNA) by clonoSEQ to monitor residual disease after axicabtagene ciloleucel (axi-cel) in large B-cell lymphoma (LBCL)
9个月前
已关闭
MRD Status By Clonoseq ® Is a Poor Predictor of Long-Term Outcomes after Bispecific LV20.19 CAR T-Cell Therapy for Relapsed, Refractory B-Cell NHL
9个月前
已关闭
Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
9个月前
已完结
ClonoSEQ assay for the detection of lymphoid malignancies
9个月前
已完结
皖公网安备34019202002308
